References
Wenning W, Haghikia A, Laubenberger J, et al. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med. Sep 10 2009;361(11):1075–80.
Schroder A, Lee DH, Hellwig K, Lukas C, Linker RA, Gold R. Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis. Arch Neurol. Nov 2010;67(11):1391–4.
Sahraian MA, Radue EW, Eshaghi A, et al. Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis. Eur J Neurol. 2012;19:1060–9.
De Stefano N, Filippi M. MR spectroscopy in multiple sclerosis. J Neuroimaging. Apr 2007;17(Suppl 1):31–5.
Matthews PM, Tampieri D, Berkovic SF, et al. Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome. Neurology. Jul 1991;41(7):1043–6.
Conflict of Interest
The authors declare that there are no actual or potential conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Berghoff, M., Dassinger, B., Iwinska-Zelder, J. et al. A Case of Natalizumab-associated Progressive Multifocal Leukoencephalopathy—Role for Advanced MRI?. Clin Neuroradiol 24, 173–176 (2014). https://doi.org/10.1007/s00062-013-0216-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00062-013-0216-z